These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10221605)

  • 1. A prospective study on the occurrence of autoantibodies in low-risk pregnancies.
    Matthiesen LS; Berg G; Ernerudh J; Skogh T
    Eur J Obstet Gynecol Reprod Biol; 1999 Mar; 83(1):21-6. PubMed ID: 10221605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte subsets and autoantibodies in pregnancies complicated by placental disorders.
    Matthiesen L; Berg G; Ernerudh J; Skogh T
    Am J Reprod Immunol; 1995 Jan; 33(1):31-9. PubMed ID: 7619232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia.
    Faden D; Tincani A; Tanzi P; Spatola L; Lojacono A; Tarantini M; Balestrieri G
    Eur J Obstet Gynecol Reprod Biol; 1997 May; 73(1):37-42. PubMed ID: 9175687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor pregnancy outcome and anticardiolipin antibodies.
    De Carolis S; Caruso A; Ferrazzani S; Carducci B; De Santis L; Mancuso S
    Fetal Diagn Ther; 1994; 9(5):296-9. PubMed ID: 7818777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women.
    Katano K; Aoki A; Sasa H; Ogasawara M; Matsuura E; Yagami Y
    Hum Reprod; 1996 Mar; 11(3):509-12. PubMed ID: 8671255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
    Laskowska M; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
    Cetin I; Cozzi V; Pasqualini F; Nebuloni M; Garlanda C; Vago L; Pardi G; Mantovani A
    Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy.
    Yasuda M; Takakuwa K; Tokunaga A; Tanaka K
    Obstet Gynecol; 1995 Oct; 86(4 Pt 1):555-9. PubMed ID: 7675379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticardiolipin antibodies in pre-eclampsia and intrauterine growth retardation.
    D'Anna R; Scilipoti A; Leonardi J; Scuderi M; Jasonni VM; Leonardi R
    Clin Exp Obstet Gynecol; 1997; 24(3):135-7. PubMed ID: 9478297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
    Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
    J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble HLA-DR levels in the maternal circulation of normal and pathologic pregnancy.
    Steinborn A; Rebmann V; Scharf A; Sohn C; Grosse-Wilde H
    Am J Obstet Gynecol; 2003 Feb; 188(2):473-9. PubMed ID: 12592258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation.
    Friedman SA; de Groot CJ; Taylor RN; Golditch BD; Roberts JM
    Am J Obstet Gynecol; 1994 Mar; 170(3):838-41. PubMed ID: 8141213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the maternal and umbilical VEGF-A and SVEGF-R1 altered in pregnancies complicated by preeclampsia with or without intrauterine foetal growth retardation? Preliminary communication.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    Med Wieku Rozwoj; 2008; 12(1):499-506. PubMed ID: 18663270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
    Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
    Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases.
    Petraglia F; Luisi S; Benedetto C; Zonca M; Florio P; Casarosa E; Volpe A; Bernasconi S; Genazzani AR
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2991-5. PubMed ID: 9284732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal outcome in women with primary Sjögren's syndrome. A retrospective case-control study.
    Julkunen H; Kaaja R; Kurki P; Palosuo T; Friman C
    Clin Exp Rheumatol; 1995; 13(1):65-71. PubMed ID: 7774105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies in women at risk for preeclampsia.
    Branch DW; Porter TF; Rittenhouse L; Caritis S; Sibai B; Hogg B; Lindheimer MD; Klebanoff M; MacPherson C; VanDorsten JP; Landon M; Paul R; Miodovnik M; Meis P; Thurnau G;
    Am J Obstet Gynecol; 2001 Apr; 184(5):825-32; discussion 832-4. PubMed ID: 11303189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of asymmetric dimethylarginine throughout normal pregnancy and in pregnancies complicated with preeclampsia or had a small for gestational age baby.
    Rizos D; Eleftheriades M; Batakis E; Rizou M; Haliassos A; Hassiakos D; Botsis D
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1311-5. PubMed ID: 22010788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of antinuclear antibody testing in unexplained second and third trimester fetal deaths.
    Incerpi MH; Banks EH; Goodwein SN; Samadi R; Goodwin TM
    J Matern Fetal Med; 1998; 7(2):61-4. PubMed ID: 9584815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.